ACTRN12611000195954已完成未知
Pharmacokinetics of Doripenem in Critically Ill Patients receiving Continuous Veno-Venous Haemodialfiltration
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •Critical illness
- •- Acute kidney injury
- •- Receiving continuous venovenous haemodialfiltration
- •- Clinical indication for doripenem
排除标准
- •- Pregnancy
- •- Allergy to doripenem
研究者
相似试验
已完成
4 期
Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma PatientsSepsisNCT01027897Emory University30
已完成
4 期
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic PatientsFebrile NeutropeniaNCT01401010Gary E. Stein, Pharm.D.12
进行中（未招募）
1 期
Target site pharmacokinetics of doripenem at steady state in intubated intensive care patients - Dori_MD_ICEUCTR2011-000035-89-ATMed. Univ. Wien, Klinik für klinische Pharmakologie20
进行中（未招募）
不适用
Multiple-dose Pharmacokinetics of Doripenem during continuous venovenous hemodiafiltration and molecular adsorbent recirculating system in ICU patients and during hemodialysis in longterm hemodialysis patients.EUCTR2009-018010-18-ATMedizinische Universität Wien, Univ.Klinik f.Innere Medizin I,Abt. f. Infektionen u.Tropenmedizin
进行中（未招募）
不适用
Pharmacokinetics of critically ill patients with invasive candidiasis - Pharmacokinetics of anidulafungiinvasive candidiasisMedDRA version: 12.0Level: LLTClassification code 10064954Term: Invasive candidiasisEUCTR2009-016386-28-NLniversity Medical Center Groningen